Edito
|
i-MEET 2016 took place on June 2 & 3 in Nice, at the Radisson Blu Hotel, on the French Riviera.
Over the 2 day meeting, our wide-ranging, interactive program included the whole range of endovascular techniques and procedures with particular focus on Femoropopliteal, Ambulatory management and BTK disease, thoracic aortic dissection, EVAR challenges and carotid stenosis. Two sessions were also dedicated to venous diseases and thrombectomy. Thanks to the animators, the speakers and moderators were interacting with the audience, providing more discussions and exchanges than ever.
i-MEET 2016 « next generation » is a new congress format based on interactivity dedicated to the current endovascular hot topics. It focuses on teaching and sharing and is a pioneer in the Live education.
MEET Directors
Nicholas Cheshire, Koen Deloose, Eric Ducasse, Yann Gouëffic, Mario Lachat, Julien Lemoine, Nicola Mangialardi, Richard McWilliams, Peter Schneider, Isabelle Van Herzeele
MEET Venous Directors
Paul Pittaluga, Sylvain Chastanet
Webinar Director
Max Amor
|
Program
|
Thursday June 2
|
|
|
08.00 Practical approach to BTK-disease, based on state of the art data
|
|
Animator: E. Ducasse |
|
Moderators: V. Alexandrescu, R. Ferraresi, P. Schneider |
|
08.00 Lecture. Inflation with or without drugs BTK? R. Ferraresi |
|
08.05 Cases, A. Schmidt |
|
08.05 Cases, J. Fernandez Noya |
|
08.25 Lecture. Scaffolding with or without drugs BTK? M. Werner |
|
08.30 Cases, L. Maene, M. Werner |
|
09.00 Lecture. Final judgement about angiosome theory: myth or fact? V. Alexandrescu |
|
09.05 Cases, P. Goverde, R. Ferraresi |
|
09.25 Lecture. Distal bypass surgery, dead in the water? P. Schneider |
|
09.30 Cases, J. Fernandez Noya, P. Schneider |
|
09.50 Lecture. « Pour finir en beauté »: woundcare and offloading principles, K. Deloose |
10.45 To close or not to close?
|
|
Animator: K. Deloose |
|
Is it still a question (for large access)? S. Haulon |
11.15 TAA - Part 1
|
|
Animator: B. Mees |
|
Moderators: L. Canaud, N. Mangialardi, F. Pecoraro |
|
Debate |
|
11.15 - There is no U-turn for the endovascular treatments, F. Pecoraro |
|
Hot Topics |
|
11.36 - Scallop-graft for the arch repair, my experience, J-M. Alsac |
|
11.44 - Chimps and regular are still a valuable option for arch repair, S. Ronchey |
|
Tips and Tricks |
|
11.57 - fEVAR and branch graft for aortic dissection repair, S. Haulon |
|
12.05 - Aortic dissection: where is the important focus during rst days/weeks? N. Cheshire |
|
12.13 - Endovascular management (petticoat technique) for the type B dissection, L. Canaud |
|
12.21 - Tevar is the first line treatment S.Ronchey |
|
12.29 - Hybrid repair for aortic dissection, indication and state of the art, F. Pecoraro |
|
12.37 - News from imaging and 3D-printing for aortic dissection comprehension, L. Maene |
14.00 TAA - Part 2
|
|
Animator: B. Mees |
|
Moderators: L. Canaud, N. Mangialardi, F. Pecoraro |
|
Real world TAA Case Extravaganza |
|
14.00 - How would you treat it? Challenging scenarios that stump the experts, L. Canaud |
|
Points of interest |
|
14.08 - Real incidences of endoleaks after TEVAR, R. McWilliams |
14.20 AAA
|
|
Animator: K. Deloose |
|
Moderators: E. Jean-Baptiste, B. Mees, N. Mosquera |
|
Debate |
|
14.20 - Are we pushing too far the frontiers of EVAR? E. Steinmetz |
|
14.28 - There are no limits using EVAR for AAA! F. Noya |
|
Hot Topics |
|
14.36 - Best practice in fEVAR in 2016, B. Mees |
|
14.44 - EVAS and chEVAS will replace EVAR and chEVAR, F. Torella |
|
14.52 - Chimps and regular devices are still a valuable option, F. Pecoraro |
|
15.00 - Ultra low profile device: behind the boundaries! X. Bérard |
|
Tips and Tricks |
|
15.08 - Management of the hypogastric artery during EVAR, F. Torella |
|
15.16 - Perfect proximal anchorage. Does it solve all the problems? J-P. de Vries |
|
15.24 - Management of challenging iliac accesses and leg thrombosis prevention, A Mansilha |
|
15.32 - The usage of covered balloon expandable stent in Ch-EVAR/S procedures, J-P. de Vries |
|
15.40 - Physician-made versus regular fenestration, is there a difference? E. Ducasse |
|
Real World AAA Case Extravaganza |
|
15.56 - How would you treat it? Challenging scenarios that stump the experts, B. Mees, T. Larzon |
|
Points of Interest |
|
16.12 - How to deal with type 1 endoleaks? N. Cheshire |
|
16.20 - Diagnosis and management of type 3b endoleak, R. McWilliams |
|
16.28 - Sorry to curb the enthusiasm, but how to treat the infected endografts? X. Berard |
17.30 Venous & thrombectomy
|
|
Moderators: S. Chastanet, P. Pittaluga |
|
17.30 Would you treat it? Challenging scenarios that stump the expert. B.Mees |
|
17.30 What might bring a new wave length for endovenous laser? L. Kabnick |
|
17.40 Should we really treat varicose tributaries? S. Onida |
|
18.00 Hemodynamics of development of the varicose disease: do we really have a new knowledge? S. Onida |
|
18.10 Endovenous treatment of the short saphenous vein: as good as for the great saphenous vein? P. Nicolini |
|
18.20 Endovascular treatment of extended iliac vein occlusion: what are the limits? A. Davies |
|
18.30 What will be the treatment of varicose veins in the future? R. Milleret |
|
18.40 Management strategies for patients with varicose veins (C2-C6): results of a worldwide survey, A. Davies |
Friday June 3
|
08.15 Modern approach of carotid artery disease
|
|
Animator: P. Schneider |
|
Moderators: M. Amor, I. Van Herzeele |
|
Debate |
|
08.15 Key articles from the past year that will influence carotid artery disease treatment going forward, I. Van Herzeele |
|
08.23 - Urgent repair of carotid disease causing stroke means it should be done within 48 hours, A. Mansilha |
|
08.31 - Urgent repair after stroke has a higher perioperative risk and I never do it in the first two weeks, N. Hopkins |
|
Hot Topic |
|
08.50 - If you want to prove that your outcomes are excellent, then perform DW-MRI in all CEA and CAS patients, I. Van Herzeele |
|
Tips and tricks: how I do it |
|
09.00 - Troubleshooting during carotid endarterectomy, C. Setacci |
|
09.08 - Ideal toolkit for carotid stenting. How to customize your approach for different types of cases, M. Amor |
|
Real-World Carotid Case Extravaganza |
|
09.30 - How would you treat it? Challenging scenarios that stump the experts, N. Hopkins, P. Montorsi |
|
09.50 - Future of carotid revascularization (include Mesh covered stents, prox protection, new designs, transcervical), P. Schneider |
|
10.00 - Standard operating protocol in stroke management at my hospital – a multidisciplinary approach is mandatory, A. Halliday |
|
10.08 New micromesh carotid stent, M. Amor |
11.00 Venous & thrombectomy
|
|
Moderators: R. Milleret, P. Nicolini |
|
11.00 The glue for the treatment of varicose veins? L. Kabnick |
|
11.08 Post-operative compression after varicose vein treatments: yes or no? R. Bootun |
|
11.16 Indications for the treatment of pelvic varices, P. Nicolini |
|
11.24 Treatment of acute venous femoro-iliac thrombosis: change the paradigm? R. Bootun |
|
11.32 Endovenous thermal ablations: consensus and polemics, L. Kabnick |
|
11.40 Foam sclerotherapy: the best cost-effectiveness treatment for varicose veins? R. Milleret |
12.00 How BMS and POBA history?
|
|
Moderators: Y. Gouëffic, K. Deloose |
|
The usage of DET in my practice, J. Sobocinski, G. Goyault |
13.30 Femoropopliteal disease & Ambulatory
|
|
Endovascular repair for long femoropopliteal lesions |
|
Animator: K. Deloose |
|
Moderators: Y. Gouëffic, J. Lemoine |
|
13.30 State of art, P. Schneider |
|
13.40 Missing data, G. Torsello |
|
Real world |
|
14.00 - Long FP lesions with supera, L. Maene |
|
14.10 - Long FP lesions with laser, E. Ducasse |
|
14.20 - Long FP lesions with reentry/pedal access, M. Di Primio |
14.50 Ambulatory management for PAD endovascular treatment
|
|
Animator: E. Steinmetz |
|
Moderators: L. Maene, G. Torsello |
|
14.50 State of art, P. Schneider |
|
15.00 Missing data, F. Airoldi |
|
15.20 Real life, Y. Gouëffic |
|
Debate |
|
15.30 - For 4F devices with 0.018, O. Regnard |
|
15.40 - For 5F devices with 0.035, F. Airoldi |
|
|
|
16.10 - Outpatients management is profitable, Y. Gouëffic |
|
|
|
|
